METHODS: A cross-sectional study was conducted with a sample of 326 patients from three tertiary care hospitals in the United Arab Emirates. The frequency and severity of urogenital symptoms, emotional and physical functioning, and treatment burden were assessed using the validated genitourinary syndrome of menopause symptoms and vaginal treatments acceptability questionnaire (GSM-SVATQ). To examine the mediating roles of emotional and physical functioning, as well as the perceived treatment burden on sexual functioning, a partial least squares-structural equation model was developed using the SmartPLS 4 Software.
RESULTS: The measurement model was successfully established. All constructs had a reliability of > 0.70 and discriminant validity of < 0.90. Emotional, physical and sexual functioning showed an adjusted R2 values of 0.377, 0.282 and 0.169, respectively.The multistep multiple mediator model revealed a full mediation effect of both emotional and physical functioning between symptom, treatment burden and sexual functioning. The model showed high predictive performance with all manifest variables showing lower mean absolute errors compared to the naiive benchmark model.
CONCLUSION: This study enhances our understanding of the relationships between urogenital symptoms, perceived treatment burden, emotional functioning, and sexual well-being. The findings emphasize the importance of addressing emotional well-being in managing urogenital symptoms and in addressing emotional factors associated with the use of vaginal treatments.
METHODS: Developed acoustic-solution-sonication-casting methods were applied to fabricate the new graphene-polymer-dental filler nanocomposites. The structure, morphology, rheological and mechanical properties, and antibacterial of the newly fabricated filling-PMMA/ GO nanocomposites were investigated.
RESULTS: Fourier transform infrared (FTIR) showed a significant interaction between the filling and the additional materials. The X-ray diffraction (XRD) analysis revealed a considerable change in crystalline behavior. Optical microscope (OM) with field emission scanning electron microscopy (FESEM) pictures demonstrated a substantial change in the morphology of the samples with a homogeneous and fine dispersion of the nanomaterials in the filler matrix. Multi-frequency ultrasound mechanical properties measured the ultrasonic velocity, absorption coefficient, compressibility, bulk modulus, and other mechanical properties that notably enhanced after GO contributed up to 325% of the ultrasonic absorption coefficient compared with hybrid/nano-fillers. Rheological properties were measured as viscosity, absorption coefficient, and specific viscosity, which significantly improved after adding PMMA and incorporating GO up to 57% of the viscosity, compared with hybrid/nano-fillers. The inhibition zone of moth bacteria, such as Enterococcus faecalis and E. staph bacteria, improved after the contribution of GO nanosheets up to 46%.
CONCLUSION: Nanofillers nanocomposites presented better properties and inhabitances zone diameter of antibacterial.
METHODS: The study encompassed a comprehensive three-stage approach to the development and validation of the PROM. Initially, during the preliminary design stage, the necessity for a new PROM was recognized, an expert panel was formed, and semi-structured qualitative interviews were carried out with GSM patients. In the second stage, the study used the five-step pre-validation methodology established by Prior et al. to generate and refine the PROM items. The third and final stage encompassed the determination of scale and item content validity indexes to ensure validity. Additionally, the reliability of each construct was evaluated using Cronbach's α.
RESULTS: The resulting PROM was named GSM-SVTAQ (GSM-symptoms and vaginal treatments acceptability questionnaire). It demonstrated excellent validity in assessing symptoms burden, health-related and sexual quality of life, and vaginal treatment acceptability, with high content validity indices and strong internal consistency. The scale content validity indices and Cronbach's α coefficients for the three domains were (0.926, 0.939), (0.875, 0.947), and (0.824, 0.855), respectively.
CONCLUSION: The GSM-SVTAQ stands as the first GSM-specific, valid, and reliable PROM capable of comprehensively measuring the three components of GSM and the acceptability of vaginal treatments. Its implementation has the potential to significantly enhance patient care and outcomes in GSM management.